Core Insights - The conference themed "A New Chapter, Building the Future" highlighted the future trends of pharmaceutical instant retail and explored new paths for high-quality growth [1] - JD Health emphasized the importance of a user, supply chain, and logistics-centric ecosystem for instant retail, introducing a growth triangle model focused on supply, experience, and users [1] Group 1: Market Trends - Instant retail has become the main growth engine for the pharmaceutical health sector, driven by the rising health consciousness among younger consumers [2] - JD Health reported a 16% year-on-year increase in the proportion of users under 30 for its instant delivery service, with student users increasing by 11.5% year-on-year [2] - The market for instant retail is projected to exceed 1 trillion yuan by 2025, growing at a rate of 29%, and surpass 2 trillion yuan by 2030 [2] Group 2: Capability Building - JD Health is building a "super pharmaceutical supply chain" as the foundation for its instant retail capabilities, focusing on a growth triangle model of supply, experience, and users [3] - The supply side has achieved nationwide coverage with a network spanning over 2,600 counties and cities, supported by over 200,000 delivery personnel, enabling delivery in as fast as 9 minutes [3] - Since April 2025, the number of JD Health's instant delivery pharmacies has increased by over 100% year-on-year, with order volume growing over 200% [3] Group 3: User Engagement - JD Health leverages its base of over 600 million active users to enhance channel operations and search recommendation mechanisms, transitioning from "people finding medicine" to "medicine finding people" [4] - The company provides scenario-based marketing solutions aligned with seasonal diseases and major promotional events to improve user engagement and conversion rates [4] Group 4: Collaborative Growth - JD Health's collaboration with partners has demonstrated significant results, such as reducing inventory turnover days for partners like Hongyu Pharmaceutical through access to JD Health's instant delivery network [5] - The Asia-Pacific region is identified as a growth engine for the self-care market, with strong consumer demand in pain management and allergy relief [5] - Looking ahead to 2026, JD Health plans to focus on specialization in instant retail and will open up data capabilities, traffic resources, and operational tools to partners [5]

Core Insights - JD Health reported Q3 2025 revenue of 17.12 billion RMB, a year-on-year increase of 28.7%, and a net profit of 1.90 billion RMB, up 42.4% year-on-year, reflecting sustained growth and the long-term value of its "super pharmaceutical supply chain" [2][3][4] Financial Performance - Q3 revenue reached 17.12 billion RMB, marking a 28.7% increase year-on-year [2] - Net profit for the quarter was 1.90 billion RMB, representing a 42.4% year-on-year growth [2] Business Model and Strategy - JD Health has evolved beyond a mere "pharmaceutical e-commerce" platform, integrating a robust supply chain with comprehensive health management services [3][4] - The company focuses on addressing unmet needs in the healthcare sector, such as improving access to innovative drugs and providing ongoing patient support [2][4] Collaborations and Partnerships - In Q3, JD Health collaborated with major pharmaceutical companies like Eli Lilly and Eisai, enhancing its supply chain capabilities [4][5] - The company launched over 30 innovative drugs online in Q3 alone, surpassing the total for the first half of the year [5] Market Expansion and Global Reach - At the China International Import Expo, JD Health partnered with 21 top health brands from 11 countries, facilitating their entry into the Chinese market [6] - The company aims to integrate global health resources into everyday life, ensuring accessibility for consumers [6] Supply Chain and Logistics - JD Health's supply chain is designed to meet diverse health needs, ensuring stable supply for both common and rare medications [7][8] - The company has implemented advanced logistics solutions, including temperature-controlled storage, to ensure the safe delivery of pharmaceuticals [10] Technological Innovation - AI technology plays a crucial role in optimizing health services, enhancing patient management, and improving operational efficiency [12][13] - JD Health has developed an AI hospital model that streamlines the patient journey, reducing wait times and improving service delivery [12][13] Consumer Engagement and Health Management - The company has introduced AI-driven health management tools, providing personalized health advice and support to users [14][15] - JD Health's services have expanded to include at-home healthcare options, catering to the needs of elderly and chronically ill patients [15] Conclusion - JD Health's commitment to long-term value creation and its focus on integrating technology into healthcare services position it as a leader in the evolving health market [16]

Core Insights - JD Health achieved record high sales during the 2025 11.11 shopping festival, with over 7,000 brands doubling their transaction volume compared to the previous year [1] - The integration of a "super pharmaceutical supply chain" and advanced digital technologies has positioned JD Health as a key player in the health industry, enhancing sales and creating a win-win ecosystem [2] Group 1: Health Consumption Trends - There is a significant increase in health consumption awareness among consumers, leading to a diverse and intelligent consumption trend [3] - Over 2,500 pharmaceutical brands saw their transaction volume double, with innovative original drugs also experiencing a doubling in sales [3] - Nutritional consumption is undergoing a transformation, with over 2,500 health and nutrition brands doubling their sales, and specific categories like health supplements seeing over 200% growth [3] Group 2: Professional Health Services - The demand for professional health services is rising, with JD Health leveraging its "medical testing, diagnosis, and treatment" service model to meet diverse consumer needs [4] - The JD Internet Hospital has improved online consultation services, with over 90% of video consultations being completed within 9 seconds [4] - AI-driven services, including AI doctors and nutritionists, are providing around-the-clock support, with a significant increase in user engagement and satisfaction [4] Group 3: Future Outlook - JD Health aims to continue enhancing its role as the primary online health consumption entry point, making quality medical products and services more accessible [5]

Core Insights - The eighth China International Import Expo saw JD Health establish partnerships with numerous multinational pharmaceutical companies and health brands, surpassing previous collaboration scales and focusing on top global pharmaceutical brands [1][2][3] - JD Health is leveraging its "super pharmaceutical supply chain" to empower companies and transition partnerships from simple channel cooperation to building a health ecosystem [1][3] Group 1: Strategic Collaborations - JD Health and Eli Lilly upgraded their strategic partnership during the expo, discussing future plans in diabetes care [2] - A strategic cooperation agreement was signed between JD Health and Kasey, focusing on disease education and chronic disease management [2][3] - JD Health is a key partner for Novo Nordisk, collaborating on a comprehensive service model for obesity and diabetes management [3] - Bayer and JD Health initiated a women's health literacy enhancement program, integrating medical resources and building a professional content library [3] - Sanofi and JD Health signed an ecological cooperation agreement to establish a Type 1 diabetes management center [3] Group 2: Market Dynamics - The outpatient market is becoming a critical battleground for pharmaceutical companies, shifting from a secondary option to a primary focus due to changes in patient consumption habits and healthcare policies [6][7] - JD Health is addressing the complexities of the outpatient market by offering a unified platform for pharmaceutical companies, reducing communication costs and enhancing operational efficiency [7] - The online pharmaceutical sales market is projected to grow, with JD Health leveraging over 200 million active users to enhance its digital marketing capabilities [8] Group 3: Internet Healthcare Transformation - The internet healthcare sector is reshaping patient treatment habits, with JD Health enhancing its services to meet evolving consumer health needs [10][11] - JD Health's internet hospital is facilitating a closed-loop service for flu prevention, allowing online consultations and prescription management [10] - The company is developing specialized healthcare services across various fields, providing a comprehensive approach to chronic disease management [11] Group 4: Future Outlook - The Chinese pharmaceutical retail market is expected to reach 501.9 billion yuan in 2024, with online sales growing faster than traditional retail [8] - JD Health aims to continue building an integrated healthcare service ecosystem, focusing on user-centered value creation and supply chain advantages [11]